Seagen Inc.
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

Last updated: 17 Aug 2022

Abstract:

This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.

Status:

Application

Type:

Utility

Filling date:

25 Apr 2022

Issue date:

11 Aug 2022

Full patent description

Patent application document